ME

Mario Ehlers

AP Amylin Pharmaceuticals: 7 patents #23 of 151Top 20%
BI Bionebraska: 2 patents #13 of 25Top 55%
AL Astrazeneca Pharmaceuticals Lp: 1 patents #40 of 76Top 55%
📍 Lincoln, NE: #107 of 1,303 inventorsTop 9%
🗺 Nebraska: #401 of 5,697 inventorsTop 8%
Overall (All Time): #503,087 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11129805 Dual ACE C-domain/NEP inhibitors Edward Sturrock 2021-09-28
8551947 Treatment of hibernating myocardium with an exendin peptide Thomas R. Coolidge 2013-10-08
7981861 Method of performing angioplasty with a GLP-1 molecule Thomas R. Coolidge 2011-07-19
RE41288 Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain Thomas R. Coolidge 2010-04-27
7056887 Treatment of acute coronary syndrome with GLP-1 Thomas R. Coolidge 2006-06-06
6982248 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue Thomas R. Coolidge 2006-01-03
6894024 Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide Thomas R. Coolidge 2005-05-17
6706689 Treatment of acute coronary syndrome with GLP-1 Thomas R. Coolidge 2004-03-16
6429197 Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain Thomas R. Coolidge 2002-08-06
6284725 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue Thomas R. Coolidge 2001-09-04